US presidential candidate Bernie Sanders pledges to allow Americans to import drugs from Canada
August 2, 2019Medical Communications Bernie Sanders, Canada, Trump, US, democrats, prescription drugs
Democratic presidential candidate Bernie Sanders has said he will, on his first day in office, allow for the importation of …
Janssen returns rights for experimental cancer immunotherapy to Alligator Bioscience, sending shares spiraling by 40%
August 1, 2019Sales and Marketing Alligator Bioscience, Janssen, pahrma
Janssen has decided to hand back the rights to an experimental CD40 agonistic antibody to Alligator Bioscience as it reassesses …
Novartis’ Kisqali reinforces overall survival benefit in postmenopausal HR+/HER2- breast cancer
August 1, 2019Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma
New Phase 3 evidence has emerged on the efficacy of Novartis’ Kisqali (ribociclib) in combination with AstraZeneca’s Faslodex (fulvestrant) in …
GSK closes the deal with Pfizer over $9.8 billion consumer healthcare merger
August 1, 2019Sales and Marketing GSK, Pfizer, merger, pharma
The $9.8 billion joint venture between major pharma firms GlaxoSmithKline and Pfizer to merge their consumer health operations has come …
Bayer’s Xarelto combo greenlighted by NICE for reducing CV events in artery disease
August 1, 2019Sales and Marketing NHS, NICE, UK, Xarelto, cardiovascular disease, pharma
NICE has awarded final appraisal recommendation to Bayer’s Xarelto (rivaroxaban) at a dosage of 2.5mg twice daily in combination with …
FDA steps up 2018 drug approvals by 11% on previous year
August 1, 2019Sales and Marketing EMA, FDA, drug approvals, pharma
The FDA continues to excel in the ground it covers as it emerges that the total number of new drug …
MSD to bring over 400 new jobs to North Carolina with two site expansions
July 31, 2019Manufacturing and Production, Research and Development MSD, US, pharma
MSD has announced a $650 million expansion of its existing facilities in North Carolina – a move which is bring …
Biogen & Alkermes’ multiple sclerosis drug proves “statistically superior” to Tecfidera at Phase 3
July 31, 2019Research and Development Alkermes, Biogen, multiple sclerosis, pharma
Biogen and Alkermes have unveiled new Phase 3 data for diroximel fumarate, comparing the adequacy of the therapy to Biogen’s …
Lilly’s Verzenio combo shows additional breast cancer survival benefit in new Phase 3 data
July 31, 2019Research and Development Cancer, Eli Lilly, Verzenio, breast cancer, pharma
Eli Lilly has revealed new Phase 3 data on its CDK4 & 6 inhibitor Verzenio (abemaciclib), demonstrating its efficacy in …
Bayer and Orion’s Nubeqa secures FDA approval in non-metastatic castration-resistant prostate cancer
July 31, 2019Research and Development, Sales and Marketing Bayer, Cancer, Nubeqa, orion, pharma, prostate cancer
The FDA has awarded approval under its Priority Review pathway to Nubeqa (darolutamide) for the treatment of non-metastatic castration-resistant prostate …
Cigarette smoke causes superbug to become more drug resistant, study shows
July 30, 2019Research and Development AMR, MRSA, cigarettes smoke, drug resistance, pharma, smoking
Cigarette smoke can make certain strains of the bacteria Methicillin-resistant Staphylococcus aureus (MRSA) more resistant to antibiotics, according to a …
Bayer’s Vitravki poised to become first tumour-agnostic therapy in EU following CHMP recommendation
July 30, 2019Manufacturing and Production, Sales and Marketing Bayer, CHMP, Cancer, EU, Vitrakvi, pharma
Bayer’s oral TRK inhibitor Vitrakvi (larotrectinib) could be set to become the European Union’s first drug approved in a tumour-agnostic …
Extremely antibiotic resistant superbugs spreading in hospitals across Europe
July 30, 2019Manufacturing and Production AMR, Antibiotics, drug resistance, drug resistant bacteria, pharma
Antibiotic resistant superbugs are spreading in hospitals in Europe, according to a study published in Nature Microbiology. The research shows …
MSD’s Keytruda combo hits primary endpoint at Phase 3 in triple-negative breast cancer
July 30, 2019Manufacturing and Production, Research and Development Cancer, MSD, breast cancer, keytruda, pharma
MSD’s blockbuster anti-PD-L1 immunotherapy Keytruda (pembrolizumab) has impressed in newly released Phase 3 data; the company announced that, when combined …
Teva, Endo and Teikoku pay $70 million settlement to California
July 30, 2019Manufacturing and Production
Three pharmaceutical companies have agreed to pay $70 million to the state of California for keeping drug prices artificially high. …
Pfizer to combine off-patent drug unit Upjohn with Mylan
July 30, 2019Manufacturing and Production M&A, MA, Mylan, Pfizer, Upjohn, biosimilars, generics, mergers
Pfizer’s off-patent drug unit Upjohn is combining with Mylan to create a new global pharmaceutical company focused on the low-price …
The patient is always right: Extracting the full value of PROMs
July 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma
Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
Roche’s Tecentriq combo recommended in Europe for non-small cell lung cancer
July 29, 2019Sales and Marketing Cancer, NSCLC, Roche, lung cancer, pharma, tecentriq
Riche’s blockbuster immunotherapy Tecentriq (atezolizumab) is closing in on securing yet another approval after it revealed that the drug was …
Sanofi ends partnership with Lexicon after release of Phase 3 data
July 29, 2019Sales and Marketing Lexicon, Sanofi, Zynquista, diabetes, pharma
French firm Sanofi has said it is ending its partnership with Texas-based firm Lexicon Pharmaceuticals over the development of diabetes …
FDA issues warning to CBD company Curaleaf
July 29, 2019Sales and Marketing CBD, FDA, cannabidiol, curaleaf, pharma, regulation
The FDA has issued a warning to Massachusetts-based CBD company Curaleaf over the firm’s use of unsubstantiated claims about the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
